FDA Panel Backs Novel Combination Inhaler for Asthma in Adults Only

(MedPage Today) -- An FDA advisory panel on Tuesday gave near unanimous backing to a novel two-drug combination inhaler for use in adults with asthma, while rejecting the product for younger children. By a 16-1 margin, the FDA's Pulmonary-Allergy...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news